// Company Overview //
| Stock Name | 京東健康股份有限公司 |
| Stock Code | 06618 |
| Company Full Name | 京東健康股份有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國經營在線零售藥房及提供在線醫療健康服務。 |
| Listing Date | 2020-12-08 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | No data |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市大興區亦莊經濟技術開發區科創十一街18號院C座8樓 |
| Business Address (Hong Kong) | No data |
| Place of Incorporation | No data |
| Listing Method | No data |
| Listing Board | Main Board |
| Website | https://ir.jdhealth.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
// Offering Information //
| Prospectus Date | 2020-11-26 |
| Offer Price | HK$ 70.58 / shares |
| Total Funds Raised | HK$ 2,964,995,220 |
// Valuation & Financials //
| Market Cap (at Offer Price) | HK$ 0 |
// First Day Performance
| First Day Close | Loading... |
| First Day Open | HK$ 94.5 |
| First Day Change | 55.85% |
| First Day Volume | 156500000.0 |
| First Day Turnover | 16039300000.0 |
// Price Chart //
// Use of Proceeds
| Use of Proceeds | 1、約40%募集資金凈額(或約10,583百萬港元)預計在未來36至60個月將用于業務擴張;
2、約30%募集資金凈額(或約7,937百萬港元)預計在未來24至36個月將用于研發;
3、約20%募集資金凈額(或約5,291百萬港元)預計將用于潛在投資及收購或戰略聯盟;
4、約10%募集資金凈額(或約2,646百萬港元)預計將用于營運資金及一般公司用途。 |
// Underwriting Syndicate //
联席保荐人 (3)
Merrill Lynch (Asia Pacific) Limited
海通国际资本有限公司
瑞银证券香港有限公司
整体协调人 (9)
Merrill Lynch (Asia Pacific) Limited
海通国际证券有限公司
瑞银证券香港有限公司
华兴证券(香港)有限公司
高盛(亚洲)有限责任公司
中信里昂证券有限公司
富瑞金融集团香港有限公司
工银国际证券有限公司
中银国际亚洲有限公司
联席账簿管理人 (17)
Merrill Lynch (Asia Pacific) Limited
海通国际证券有限公司
瑞银证券香港有限公司
华兴证券(香港)有限公司
高盛(亚洲)有限责任公司
中信里昂证券有限公司
富瑞金融集团香港有限公司
工银国际证券有限公司
中银国际亚洲有限公司
建银国际金融有限公司
交银国际证券有限公司
农银国际证券有限公司
招银国际融资有限公司
国泰君安证券(香港)有限公司
星展亚洲融资有限公司
瑞穗证券亚洲有限公司
富途证券国际(香港)有限公司
联席牵头经办人 (17)
Merrill Lynch (Asia Pacific) Limited
海通国际证券有限公司
瑞银证券香港有限公司
华兴证券(香港)有限公司
高盛(亚洲)有限责任公司
中信里昂证券有限公司
富瑞金融集团香港有限公司
工银国际证券有限公司
中银国际亚洲有限公司
建银国际金融有限公司
交银国际证券有限公司
农银国际证券有限公司
招银国际融资有限公司
国泰君安证券(香港)有限公司
星展亚洲融资有限公司
瑞穗证券亚洲有限公司
富途证券国际(香港)有限公司
// Cornerstone Investors //
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
| 1 |
BlackRock Funds |
1,938,140,916 HKD |
— |
7.19% |
— |
6 months |
2021-06-08 |
| 2 |
GIC Private Limited |
2,713,398,694 HKD |
— |
10.07% |
— |
6 months |
2021-06-08 |
| 3 |
Hillhouse Funds |
1,170,498,720 HKD |
— |
4.34% |
— |
6 months |
2021-06-08 |
| 4 |
Internet Fund IIIA Pte Ltd |
2,325,769,805 HKD |
— |
8.63% |
— |
6 months |
2021-06-08 |
| 5 |
Lake Bleu Prime Healthcare Master Fund Limited |
775,254,249 HKD |
— |
2.88% |
— |
6 months |
2021-06-08 |
| 6 |
中国国有企业结构调整基金股份有限公司 |
1,544,435,089 HKD |
— |
5.73% |
— |
6 months |
2021-06-08 |
// Directors & Management //
| Chairman | 劉強東 |
| Company Secretary | 趙明璟 |
No director data available.
// Major Shareholders //
| Major Shareholders & Holdings | 京東集團股份有限公司(67.62%) |
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.